CG Oncology, Inc. (CGON) › Shareholders' EquityCG Oncology, Inc. (CGON) — Shareholders' EquityAnnual figures by period end, from SEC filings.2022-12-31: -$77.69M2023-12-31: -$123.10M2024-12-31: $733.38M2025-12-31: $752.60M$752.60M2022-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$752.60M+2.6%2026-02-27Balance as of period end2024-12-31$733.38M—2026-02-27Balance as of period end2023-12-31-$123.10M—2026-02-27Balance as of period end2022-12-31-$77.69M—2026-02-27Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)